版本:
中国

BRIEF-Intec Pharma provides update on phase III accordance study of the accordion pill

March 29 Intec Pharma Ltd:

* Intec Pharma provides update on phase III accordance study of the accordion pill carbidopa/levodopa in parkinson's disease patients

* Intec Pharma Ltd says also reported that patients who have completed accordance study have continued into open-label extension portion of trial

* Says company expects to complete enrollment in accordance study in Q4 of 2017

* Intec Pharma-current pace of patients recruitment in accordance study,reduction in study's sample size enabled reducing expected number of study's clinical sites Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐